Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Corticotropin-independent Cushing's syndrome is caused by tumors or hyperplasia of the adrenal cortex. The molecular pathogenesis of cortisol-producing adrenal adenomas is not well understood. METHODS: We performed exome sequencing of tumor-tissue specimens from 10 patients with cortisol-producing adrenal adenomas and evaluated recurrent mutations in candidate genes in an additional 171 patients with adrenocortical tumors. We also performed genomewide copy-number analysis in 35 patients with cortisol-secreting bilateral adrenal hyperplasias. We studied the effects of these genetic defects both clinically and in vitro. RESULTS: Exome sequencing revealed somatic mutations in PRKACA, which encodes the catalytic subunit of cyclic AMP-dependent protein kinase (protein kinase A [PKA]), in 8 of 10 adenomas (c.617A→C in 7 and c.595_596insCAC in 1). Overall, PRKACA somatic mutations were identified in 22 of 59 unilateral adenomas (37%) from patients with overt Cushing's syndrome; these mutations were not detectable in 40 patients with subclinical hypercortisolism or in 82 patients with other adrenal tumors. Among 35 patients with cortisol-producing hyperplasias, 5 (including 2 first-degree relatives) carried a germline copy-number gain (duplication) of the genomic region on chromosome 19 that includes PRKACA. In vitro studies showed impaired inhibition of both PKA catalytic subunit mutants by the PKA regulatory subunit, whereas cells from patients with germline chromosomal gains showed increased protein levels of the PKA catalytic subunit; in both instances, basal PKA activity was increased. CONCLUSIONS: Genetic alterations of the catalytic subunit of PKA were found to be associated with human disease. Germline duplications of this gene resulted in bilateral adrenal hyperplasias, whereas somatic PRKACA mutations resulted in unilateral cortisol-producing adrenal adenomas. (Funded by the European Commission Seventh Framework Program and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Somatic activating mutations of protein kinase A catalytic subunit (PRKACA) has been implicated in up to 50% of patients with adenomas with clinical Cushing’s syndrome, but not in adenomas producing less cortisol (138,142,147).”
From Adrenal incidentaloma (2020) · cites this paper as [147]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these mutations, the most frequently found (PKA-CL205R) is a point mutation leading to substitution of Leu at position 205 (or 206, depending on the convention used for numbering) with Arg and has been found in up to 67% of Cushing’s syndrome patients (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The L205R mutation was discovered independently in our laboratory and in other laboratories as the dominant genetic alteration in cortisol-producing adrenocortical adenomas responsible for Cushing’s syndrome (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Later on, our group and others discovered single mutations or insertions at the R/C interface that are linked to adrenal Cushing’s syndrome (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As expected, the 60-minute post-ACTH cortisol was higher than the 30-minute cortisol on each of the cortisol assays evaluated [26, 28, 38].”
From New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays (2021) · cites this paper as [38]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationNewell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153
Self-citationManagement of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945 · cited 1×
“Adrenal adenomas are common, with a prevalence of at least 3% among persons older than 50 years of age.(3) Whereas only a subset of these tumors is associated with overt Cushing’s syndrome, some degree of cortisol excess is present, depending on the diagnostic criteria applied,(4) in up to 47% of patients with adrenal…”
BackgroundThe clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt-Rasmussen, U., Hagen, C., Jørgensen, J., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 619
Beuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577
Self-citationPersistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors
Calebiro, D., Nikolaev, V. O., Gagliani, M. C., de Filippis, T., Dees, C., Tacchetti, C., Persani, L., & Lohse, M. J. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000172 · Cited by 574
Self-citationIncidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.117 · Cited by 507
Assembly of allosteric macromolecular switches: lessons from PKA
Taylor, S. S., Ilouz, R., Zhang, P., & Kornev, A. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3432 · Cited by 477
Research works printed but not linked: 1
- Bertherat J, 2003, Cancer Res, 63, 5308
Cited by
Items 301–400 of 475
Gene Mutations in Cushing’s Syndrome
Ojha, U., Ogunmwonyi, I., Xiang, J., & Ojha, H. (2022) · Molecular Syndromology · doi:10.1159/000524267 · Cited by 5
Deng, Z., Yang, Z., Li, L., Zeng, G., Meng, Z., & Liu, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-96855-1 · Cited by 5
Genetic characterization of a mouse line with primary aldosteronism
Perez‐Rivas, L. G., Rhayem, Y., Sabrautzki, S., Hantel, C., Rathkolb, B., de Angelis, M. H., Reincke, M., Beuschlein, F., & Spyroglou, A. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0200 · Cited by 5
Self-citationSomatic Mutations Associated with Aldosterone-Producing Adenomas (APAs)
Rahman, A. N. A., & Azizan, E. A. B. A. (2025) · Genes · doi:10.3390/genes16070778 · Cited by 5
McGlacken-Byrne, S. M., Abdelmaksoud, A., Haini, M., Palm, L., Ashworth, M. T., Li, J., Wang, W., Wang, X., Wang, J., Callaghan, B., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0287 · Cited by 5
Genomic insights into Cushing syndrome
Assié, G. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.03.011 · Cited by 5
Self-citationGermline targeted next-generation sequencing in patients with adrenal incidentalomas
Messina, E., Inglesi, A., Puglisi, S., Nekić, A. B., Morelli, V., Alessi, Y., Tomsic, K. Z., Palmieri, S., Tomaiuolo, P., Grosso, E., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1685220 · Cited by 4
Regulation of Adrenal Steroidogenesis
Pihlajoki, M., Heikinheimo, M., & Wilson, D. B. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_2 · Cited by 4
Turcu, A. F., & Auchus, R. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_10 · Cited by 4
Endocrinology research—reflecting on the past decade and looking to the next
Herold, K. C., Majzoub, J. A., Melmed, S. K., Pendergrass, M., & Schlumberger, M. J. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.164 · Cited by 4
Cortisol-secreting adrenocortical tumours in dogs and their relevance for human medicine
Galac, S. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.06.026 · Cited by 4
Joseph, L. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800892-8.00029-4 · Cited by 4
Narumi, H., Hasegawa, S., Waki, K., Fukuda, K., Ohnishi, Y., Ichimura, T., Fujimoto, Y., Katsura, S., Kawano, H., Ikeda, E., et al. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0145 · Cited by 4
PPNAD, Carney Complex, and Other Micronodular Adrenal Hyperplasia
Espiard, S., & Bertherat, J. Y. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64321-0 · Cited by 4
Self-citationGuo, Y., Gao, W., Wang, D., Liu, W., & Liu, Z. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0944-z · Cited by 4
Lennartz, M., Amezada, D., Höflmayer, D., Rico, S. D., von Bargen, C. M., Kind, S., Reiswich, V., Viehweger, F., Lutz, F., Bertram, V., et al. (2024) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2023-0281-oa · Cited by 4
Primary pigmented nodular adrenocortical disease
Xing, H., Ahn, J., Kim, L. H. C., & P’ng, C. H. (2023) · Pathology · doi:10.1016/j.pathol.2023.06.007 · Cited by 4
Interaction Networks Explain Holoenzyme Allostery in Protein Kinase A
Welsh, C. L., Conklin, A. E., & Madan, L. K. (2023) · Kinases and Phosphatases · doi:10.3390/kinasesphosphatases1040016 · Cited by 3
Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation
Ronchi, C. L., Di, D. G., Sbiera, S., Assié, G., Weigand, I., Calebiro, D., Appenzeller, S., Rubin, B., Waldmann, J., Scaroni, C. M., et al. (2016) · Endocrine Abstracts · doi:10.1530/endoabs.41.oc1.1 · Cited by 3
Self-citationRege, J., & Udager, A. M. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106666 · Cited by 3
Association of DNA methylation with steroidogenic enzymes in Cushing’s adenoma
Kodama, T., Oki, K., Otagaki, Y., Baba, R., Okada, A., Itcho, K., Kobuke, K., Nagano, G., Ohno, H., Hinata, N., et al. (2022) · Endocrine Related Cancer · doi:10.1530/erc-22-0115 · Cited by 3
Kelsall, A., & Newell-Price, J. D. C. (2021) · Medicine · doi:10.1016/j.mpmed.2021.05.006 · Cited by 3
Watanabe, D., Morimoto, S., Morishima, N., & Ichihara, A. (2023) · Heart and Vessels · doi:10.1007/s00380-023-02309-x · Cited by 3
Actualités du syndrome de Cushing d’origine surrénalienne
Haissaguerre, M., & Tabarin, A. (2014) · Annales d Endocrinologie · doi:10.1016/s0003-4266(14)70025-3 · Cited by 3
Nadella, K. S., Berthon, A. S., Almeida, M. Q., Levy, I., Faucz, F. R., & Stratakis, C. A. (2021) · Endocrine · doi:10.1007/s12020-020-02583-z · Cited by 3
Self-citationImpact of kinase activating and inactivating patient mutations on binary PKA interactions
Röck, R., Mayrhofer, J. E., Bachmann, V., & Stefan, E. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00170 · Cited by 3
Comparative Proteomic Profiling of Adrenocortical Neoplasia Using Mass Spectrometry
Kremer, J. L., Ortega, H. S., Souza‐Siqueira, T., Angeli, C. B., Iwai, L. K., & Lotfi, C. F. P. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00740 · Cited by 3
Jang, I., Kim, S.-J., Song, R.-Y., Kim, K., Choi, S., Lee, J.-S., Gwon, M.-K., Seong, M. W., Lee, K. E., & Kim, J. H. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1217 · Cited by 3
Stenman, A., Murtha, T. D., Korah, R. M., & Carling, T. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-110143 · Cited by 3
Genetic Testing for Adrenal Tumors—What the Contemporary Surgeon Should Know
Bates, M. F., & Sorensen, M. J. (2023) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2022.10.007 · Cited by 3
cAMP/PKA signaling in endocrine hypertension: genetic mechanisms and pathophysiological insights
Sobrinho, J. A. B. L., & Almeida, M. Q. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1748702 · Cited by 3
PPARG dysregulation as a potential molecular target in adrenal Cushing's syndrome
Vetrivel, S., Tamburello, M., Oßwald, A., Zhang, R., Khan, A., Jung, S., Baker, J. E., Rainey, W. E., Nowak, E., Altieri, B., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1265794 · Cited by 3
Self-citationSuperficial Angiomyxoma Revisited
SHINOHARA, Y., Chijiiwa, Y., & Nishio, J. (2025) · In Vivo · doi:10.21873/invivo.14053 · Cited by 3
Majumder, S., Chakraborty, P. P., Ghosh, P. C., & Bera, M. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-236850 · Cited by 3
High prevalence of adrenal cortical adenomas in patients with cerebral meningiomas
di Filippo, L., Marca, S. L., Losa, M., Lena, M. S., Mapelli, R., Incampo, G., Mortini, P., COBELLI, F. D., Giustina, A., & Lanzi, R. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01935-y · Cited by 2
Could Targeting Hormone Receptors be an Effective Strategy in Management of Adrenal Hyperplasia?
Lefèbvre, H., Prévost, G., & Louiset, E. (2014) · International Journal of Endocrine Oncology · doi:10.2217/ije.14.10 · Cited by 2
Pathophysiology and Genetic Landscape of Adrenocortical Tumors and Hyperplasias
Ghorayeb, N. E., Bourdeau, I., & Lacroix, A. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_7 · Cited by 2
Cushing’s Syndrome and Glucocorticoid Excess
Koch, C. A. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_28 · Cited by 2
Keil, M. F., & Stratakis, C. A. (2013) · Humana Press eBooks · doi:10.1007/978-1-60761-395-4_14 · Cited by 2
Self-citationCarney Complex: A Comprehensive Review of Clinical Presentation, Genetics, and Therapeutic Advances
González, R. G., Padilla, A. M. A., Romero, J. A. O., & Verdugo, M. A. C. (2024) · International Journal of Medical Science and Clinical Research Studies · doi:10.47191/ijmscrs/v4-i01-07 · Cited by 2
White, P. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-06231-5_25 · Cited by 2
Pathogenesis of benign unilateral adrenocortical tumors: focus on cAMP/PKA pathway
Weigand, I. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02874-2 · Cited by 2
Molecular pathology of primary aldosteronism and hypercortisolism: Impact on adrenal surgery
Carling, T., Stratakis, C. A., Faucz, F. R., & Juhlin, C. C. (2026) · iScience · doi:10.1016/j.isci.2026.114910 · Cited by 2
Self-citationCáncer diferenciado de tiroides en niños
Rivera-Hernández, A. D. J., Bahena-García, A. L., Ruiz-Reyes, M. D. L. L., & Calzada-León, R. (2020) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.19001922 · Cited by 2
Molecular profile of Cushing’s syndrome
González-Pérez, C., Pedraza‐Arévalo, S., Castano, J. P., & Ibáñez‐Costa, A. (2026) · Vitamins and hormones · doi:10.1016/bs.vh.2026.04.003 · Cited by 2
Characterisation of a GNAS variant linked to cortisol-producing adrenocortical adenoma
Jamaluddin, A., Wyatt, R. A., Pasaliu, A., Ruggles, O., Calebiro, D., Gorvin, C. M., & Ronchi, C. L. (2025) · Endocrine Oncology · doi:10.1530/eo-25-0009 · Cited by 2
Self-citationGNAS, McCune–Albright syndrome, and GH-producing tumors
Peverelli, E., Treppiedi, D., Mangili, F., Catalano, R., & Mantovani, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814537-1.00009-9 · Cited by 2
The β 2 ‐adrenoceptor agonist formoterol attenuates hallmarks of adrenal Cushing's syndrome
Cleveland, K. H., Lee, K.-S., Ponnalagu, D., Vicente, J. J., Parker, E. D., Lee, J. Y. E., Wordeman, L. G., & Scott, J. D. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70370 · Cited by 2
Stratakis, C. A. (2019) · Endocrinology · doi:10.1210/en.2019-00290 · Cited by 2
Self-citationTsukamoto, Y., Kurajyoh, M., Koyama, H., Kakibuchi, M., Yamamoto, S., Miyamoto, Y., Hao, H., & Hirota, S. (2017) · Human Pathology Case Reports · doi:10.1016/j.ehpc.2017.06.003 · Cited by 2
Drougat, L., Settas, N., Ronchi, C. L., Bathon, K., Calebiro, D., Maria, A. G., Haydar, S., Voutetakis, A., London, E., Faucz, F. R., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-01018-4 · Cited by 2
Self-citationAstudillo, V. O. V., Cadena, M. B. C., Fernández, O., Sevilla, J. D. P. L., Romero, A. R. R., Carvajal, C. B. R., Yépez, J. S. E., & Luna, A. D. C. (2024) · Florence. · doi:10.56183/florence24009 · Cited by 2
PKA mutations are associated with Cushing syndrome
(2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.31 · Cited by 2
Feiteiro, J. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 2
Identification of Cushing's syndrome (CS) and its history from Harvey Cushing to today
Poirier, J., Martel‐Duguech, L., Bourdeau, I., & Lacroix, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-96100-4.00012-0 · Cited by 1
Tumores de la glándula suprarrenal
Libé, R., & Bertherat, J. Y. (2016) · EMC - Urología · doi:10.1016/s1761-3310(16)77898-4 · Cited by 1
Self-citationLerário, A. M., Mohan, D. R., Giordano, T. J., & Hammer, G. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00013-7 · Cited by 1
Ragnarsson, Ó. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00006-6 · Cited by 1
Germline and somatic genetic drivers of adrenocortical tumours
Bouys, L., & Bertherat, J. Y. (2026) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2026.102099 · Cited by 1
Self-citationCushing Syndrome—Unilateral Adrenal Adenoma
Dalmazi, G. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65213-3 · Cited by 1
Endocrine Hypertension and Chronic Kidney Disease
Koch, C. A., Pamporaki, C., & Kantorovich, V. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1982-6_16 · Cited by 1
Epigenetic reactivation of a neurodevelopmental phosphoprotein program in pituitary adenomasPreprint
Chittiboina, P., Mullaney, D., Bhatt, S., Mandal, D., Nwokoye, D., Stoica, S., Bhatt, D., Johnson, K. R., Elkhaloun, A. G., Dampier, C. H., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4768687/v1 · Cited by 1
White, P. C. (2018) · Springer eBooks · doi:10.1007/978-3-319-31107-4_25 · Cited by 1
Genetics of Benign Adrenocortical Tumors
Hannah‐Shmouni, F., & Stratakis, C. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_3 · Cited by 1
Self-citationGenetic Disorders of Adrenocortical Function
Hannah‐Shmouni, F., & Stratakis, C. A. (2018) · Endocrinology · doi:10.1007/978-3-319-44675-2_29 · Cited by 1
Self-citationGaston, L. S., & Majzoub, J. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00013-5 · Cited by 1
Mestre, J. L. (2018) · theses.fr (ABES) · doi:10.70675/cab4c4e4z049az4c9czbbefzbf46cdba1d44 · Cited by 1
Disruptions to protein kinase A localization in adrenal pathology
Omar, M. H. (2024) · Biochemical Society Transactions · doi:10.1042/bst20240444 · Cited by 1
Genetics of cortisol-secreting bilateral macro- and micronodular adrenal hyperplasias
Larose, S., Salle, S. P., Bourdeau, I., & Lacroix, A. (2024) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2024.100541 · Cited by 1
Hereditary Endocrine Tumor Registries
Moore, E. C., Ioannou, L., Ruseckaite, R., Serpell, J. W., & Ahern, S. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac194 · Cited by 1
Cushing’s Syndrome mutant PKA L205R exhibits altered substrate specificityPreprint
Lubner, J. M., Dodge‐Kafka, K. L., Carlson, C. R., Church, G. M., Chou, M. F., & Schwartz, D. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/091231 · Cited by 1
Li, Y., Duan, D., Zhu, S., Liu, Z., Zhang, Q., & Wu, L. (2025) · Communications Biology · doi:10.1038/s42003-025-08718-0 · Cited by 1
Introduction to symposium: ‘New genetics with impact on treatment of endocrine tumour disease’
(2016) · Journal of Internal Medicine · doi:10.1111/joim.12518 · Cited by 1
Mécanismes moléculaires régulés par la méthyltransférase EZH2 dans les corticosurrénalomes
Tabbal, H. (2018) · theses.fr (ABES) · doi:10.70675/218900b7z5b35z451fz9e91z7e859cef6339 · Cited by 1
Characterizing Genomic Duplication in Autism Spectrum Disorder
Higginbotham, E. J. (2020) · TSpace (University of Toronto) · Cited by 1
c-KIT oncogene expression in PRKAR1A-mutant adrenal cortex
Nadella, K. S., Faucz, F. R., & Stratakis, C. A. (2020) · Endocrine Related Cancer · doi:10.1530/erc-20-0270 · Cited by 1
Self-citationTorbenson, M. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-16089-4_8 · Cited by 1
(2015) · Folia Endocrinologica Japonica · doi:10.1507/endocrine.91.suppl.update_30 · Cited by 1
Blatkiewicz, M., Hryhorowicz, S., Szyszka, M., Suszyńska-Zajczyk, J., Pławski, A., Olechnowicz, A., Porzionato, A., Malendowicz, L. K., & Ruciński, M. (2026) · Communications Biology · doi:10.1038/s42003-026-10697-9 · Cited by 1
Wu, Q. (2021) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.28323 · Cited by 1
Kumar, P. R., Dash, B., Dash, D. K., Patro, D., Majhi, J. K., & Dhal, B. S. (2025) · JCEM Case Reports · doi:10.1210/jcemcr/luaf035 · Cited by 1
Hassan, M., Samara‐Boustani, D., Besançon, A., Rothenbühler, A., Storey, C., Pinto, G., Stoupa, A., Nicolino, M. P., González-Briceño, L., Quoc, A. N., et al. (2025) · Hormone Research in Paediatrics · doi:10.1159/000545265 · Cited by 1
Self-citationFamilial Thyroid Cancer Syndromes in Children and Adolescents
Al-Naqeeb, G., Baral, N., Welch, J. M., & Kłubo-Gwieździńska, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-37275-9_5 · Cited by 1
Protein kinase A: a quirky prototype
Gold, M. G. (2025) · FEBS Journal · doi:10.1111/febs.70176 · Cited by 1
Teixeira, M. V. (2016) · Americanae (AECID Library) · Cited by 1
Phosphoproteomic dysregulation promotes tumor proliferation in Cushing’s disease
Asuzu, D. T., Bhatt, D., Mullaney, D., Mandal, D., Nwokoye, D., Varghese, S., Lopez, D. T., Ramavenkat, N., Johnson, K. R., Elkahloun, A. G., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2528513123
Cushing's syndrome screening and differential diagnosis
Lacroix, A., & Nieman, L. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00233-8
Protein Kinase A Signaling in Cortisol Production and Adrenal Cushing’s Syndrome
Kumar, A., Sharma, A., & Omar, M. H. (2025) · Cells · doi:10.3390/cells15010063
Knowledge mapping of Cushing syndrome: A bibliometric analysis from 2000 to 2023
Lu, X., Huang, M., Yang, Y., Chen, D., Qin, F., & Huang, Q. (2025) · Medicine · doi:10.1097/md.0000000000046025
Bonnet-Serrano, F. (2021) · theses.fr (ABES) · doi:10.70675/022bf2ffz5b62z4303z9460z55629099aab6
Pereira, A. M., & Dekkers, O. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00006-8
Korrelation zwischen Nebennierenmorphologie und kardiovaskulären Parametern
Reincke, M., & Beuschlein, F. (2015)
Self-citationVaczlavik, A., & Bertherat, J. Y. (2020) · Endocrinology · doi:10.1007/978-3-319-73082-0_11-1
Self-citationVaczlavik, A., & Bertherat, J. Y. (2021) · Endocrinology · doi:10.1007/978-3-319-89497-3_11
Self-citationCavalcante, I. P. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2014.tde-12012015-125308
Correlação da expressão de GLUT1, HK1, HK2 e HK3 com alta captação de 18 F-FDG em hiperplasia
Cavalcante, I. P. (2014)
Tumores de la glándula suprarrenal
Libé, R., & Bertherat, J. Y. (2023) · EMC - Urología · doi:10.1016/s1761-3310(22)47437-8
Self-citationMolecular Pathology of Endocrine Tumors
Erickson, L. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-35118-1_21
Liang, Z., Wang, S., Lan, X., Wei, Z., & Hou, E. (2025) · Cureus · doi:10.7759/cureus.92367
Adrenal tumors causing Cushing syndrome: Genetics, molecular advances, diagnosis, and treatment
Vaduva, P., Violon, F., & Bertherat, J. Y. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-96100-4.00017-x
Self-citation
Metadata
- Authors
- Beuschlein, F., Fassnacht, M., Assié, G., Calebiro, D., Stratakis, C. A., Osswald, A., Ronchi, C. L., Wieland, T., Sbiera, S., Faucz, F. R., Schaak, K., Schmittfull, A., Schwarzmayr, T., Barreau, O., Vezzosi, D., Rizk-Rabin, M., Zabel, U., Szarek, E., Salpea, P., Forlino, A., Vetro, A., Zuffardi, O., Kisker, C., Diener, S., Meitinger, T., Lohse, M. J., Reincke, M., Bertherat, J., Strom, T. M., & Allolio, B.
- Affiliations
- University of Würzburg (DE)
- Centre National de la Recherche Scientifique (FR)
- National Institutes of Health (US)
- Helmholtz Munich (DE)
- University of Pavia (IT)
- Policlinico San Matteo Fondazione (IT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-03-13
- Volume
- 370
- Issue
- 11
- Pages
- 1019-1028
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4727447
- OpenAlex
- W2040816499
- Cited by
- 443
- References
- 40
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 28 · 2023: 26 · 2022: 39 · 2021: 40 · 2020: 28 · 2019: 25 · 2018: 34 · 2017: 38 · 2016: 51 · 2015: 50 · 2014: 38
- FWCI
- 58.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- George Washington University
- Johns Hopkins University
- Cedars-Sinai Medical Center
- Quest Diagnostics
- Otsuka America
- European Commission (259735)
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (ZIAHD008920)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- Cushing's syndrome, adrenal hyperplasia, PRKACA, protein kinase A catalytic subunit, somatic mutations, adrenocortical tumors, hypercortisolism
- MeSH terms
- Adenoma, Adrenal Gland Neoplasms, Adrenal Hyperplasia, Congenital, Adult, Cushing Syndrome, Humans, Hydrocortisone, Middle Aged, Mutation, Protein Conformation, Sequence Analysis, DNA, Cyclic AMP-Dependent Protein Kinases, Germ-Line Mutation, Catalytic Domain, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.